733 research outputs found
Arne Wendler et Johann Hendrik Nub. — Libellules
Grand David. Arne Wendler et Johann Hendrik Nub. — Libellules. In: Bulletin mensuel de la Société linnéenne de Lyon, 64ᵉ année, n°5, mai 1995. p. 233
What makes research ethical?
Tuesday, February 11, 2014; noon to 1 p.m.; Room D1.602. "What Makes Research Ethical?" David S. Wendler, PH.D., Head, Unit on Vulnerable Populations Department of Bioethics, NIH Clinical Center.Many believe that informed consent makes clinical research ethical. However, informed consent is neither necessary nor sufficient for ethical clinical research. Drawing on the basic philosophies underlying major codes, declarations, and other documents relevant to research with human subjects, this presentation proposes seven requirements that systematically elucidate a coherent framework for evaluating the ethics of clinical research studies: (1) value; (2) scientific validity; (3) fair subject selection; (4) favorable risk-benefit ratio; (5) independent review; (6) informed consent; and (7) respect for enrolled subjects. These requirements are universal, although they must be adapted to the health, economic, cultural, and technological conditions in which clinical research is conducted.UT Southwestern--Program in Ethic
Dematerialised: Jack Wendler Gallery, 1971 to 1974
This Exhibition and related publication was the product of a collaboration between Donald Smith and Teresa Gleadowe, former Director of the MA Curating course at the Royal College of Art.
The show concerned the previously unpublished collection and archive of influential collector and owner of Art Monthly magazine, Jack Wendler, who opened a small gallery in London in 1971 showing “new art” introducing American and European artists to the UK. Artists in the show included: Marcel Broodthaers, Daniel Buren, Lawrence Weiner, David Askevold, Peter Downsbrough, Robert Barry, John Baldessari.
The show consisted of original artworks, letters and instructions from the artists, and publications. In presenting the work some material was set out as a reading/research facility. The show included a facsimile copy of Jack Wendler and Seth Seiglaub's influential ‘Xerox Book’, so that the audience could experience this important document, as well as view the original artefact in a vitrine. This accessibility through facsimile was used throughout the exhibition to promote a pedagogic notion of exhibition as teaching resource. The exhibition was part of an ongoing enquiry into alternative and sometimes short lived exhibiting spaces and their curators, gallerists, and collector
Primum Seculare Iobeleum Formulae Christianae concordiae ... Celebratum Disputatione Solenni De Formulae Concordiae Publicatione
Quam Praeside ... Johanne Deutschmann ... defendet M. David Wendeler, Wittebergensis ... D. Sept. Anno M.DC.LXXX. horis ante & Post-meridiani
Dissertatio Philologica De Divini Nominis Jehova Anekphōnēsei
quam ... Sub Patrocinio ... Dn. M. Andreae Sennerti ... publico examini proponit David Wendelerus, Schletta-Misnicus Ad diem 14. Maii, In Auditorio maioriDruckvariante mit Widmung auf der Rückseite des Titelbl. - Nicht identisch mit VD17 39:153070K (dort ohne Widmung)Nicht identisch mit VD17 547:629369Q (dort ohne Widmung u. Fingerprint abweichend)Vorlageform des Erscheinungsvermerks: Wittebergae Excudebat Michael Wendt/ Anno 164
In Defense of a Social Value Requirement for Clinical Research
Many guidelines and commentators endorse the view that clinical research is ethically acceptable only when it has social value, in the sense of collecting data which might be used to improve health. A version of this social value requirement is included in the Declaration of Helsinki and the Nuremberg Code, and is codified in many national research regulations. At the same time, there have been no systematic analyses of why social value is an ethical requirement for clinical research. Recognizing this gap in the literature, recent articles by Alan Wertheimer and David Resnik argue that the extant justifications for the social value requirement are unpersuasive. Both authors conclude, contrary to almost all current guidelines and regulations, that it can be acceptable across a broad range of cases to conduct clinical research which is known prospectively to have no social value. The present article assesses this conclusion by critically evaluating the ethical and policy considerations relevant to the claim that clinical research must have social value. This analysis supports the standard view that social value is an ethical requirement for the vast majority of clinical research studies and should be mandated by applicable guidelines and policies
What we worry about when we worry about the ethics of clinical research
Clinical research is thought to be ethically problematic and is subject to extensive regulation and oversight. Despite frequent endorsement of this view, there has been almost no systematic evaluation of why clinical research might be ethically problematic. As a result, it is difficult to determine whether the regulations to which clinical research is subject address the ethical concerns it raises. Commentators who consider this question at all tend to assume that clinical research is ethically problematic because it exposes some individuals to risks for the benefit of others. Yet, many other activities that expose some individuals to risks for the benefit of others are not subject to extensive regulation and oversight. This difference raises the question of whether clinical research is distinct from these activities in normatively relevant ways and, if so, what implications this difference (or differences) has for how clinical research should be regulated and conducted. The present manuscript attempts to answer this question by comparing clinical research to two other activities that expose some individuals to risks for the benefit of others. This comparison highlights an aspect of clinical research which has received relatively little attention, namely, the active role investigators play in exposing subjects to risks. I argue that this aspect explains much of the ethical concern expressed regarding clinical research. I end by considering the normative significance of this feature and the implications it has for how clinical research should be regulated and conducted
The Permissibility of Deception in Riskier Research
The use of deception is typically prohibited in studies that pose greater than minimal risk overall. This approach prevents researchers from using deception to conceal significant risks or to deceive participants about the purpose, potential benefits, or other aspects of a study that are relevant to deciding whether to accept such risks. Yet this approach also mistakenly blocks appropriate research. In particular, it keeps researchers from using deception in studies that pose greater than minimal risk, even when participants are informed accurately about the risks and other aspects of the study that are relevant to deciding whether to participate. Rather than prohibiting deception when the overall study poses greater than minimal risk, policies should prohibit deception when the aspect of the study about which participants are deceived poses greater than minimal risk
Cum Illustris ac Excellentissimus Dominus, Dn. Gotthelff Friederich a Schönberg ... Illustrem ac Generosissimam Dominam Sabinam Elisabetham, Divi Illustris Dni. Vitzthumii De Eckstedt Relictam Viduam ... Lusatiae nuptam, Favente Numine Divino, domum duceret, Obsequiosissimam observantiam suam exhibiturus, applaudebat Illustris Ipsius Excellentiae Devotissimus coram Deo Intercessor, & humillimus Servus, D. David Wendeler, h.t. Praep. & Super. Kemberg [... d. XVI. Iul. M.DC.XXCIX.]
Exegesis Primae Partis Cap. VII. Prioris Ad Corinthios, Quae agit De Vita Coniugali, e Grotio & contra Grotium Aliorumq[ue] Corruptelas / Quam Sub Praesidio ... Dn. Abrahami Calovii ... publico eruditorum examini subiicit, M. David Wendeler, Wittebergensis. Seren. Elect. Sax. Alumnus, Ad diem 22. Octob. ...
- …
